106 filings
8-K/A
TVGN
Tevogen Bio Holdings Inc.
26 Apr 24
Financial Statements and Exhibits
9:22pm
10-K
2023 FY
TVGN
Tevogen Bio Holdings Inc.
Annual report
26 Apr 24
9:21pm
8-K
TVGN
Tevogen Bio Holdings Inc.
26 Apr 24
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
8:30am
8-K/A
TVGN
Tevogen Bio Holdings Inc.
10 Apr 24
Entry into a Material Definitive Agreement
5:06pm
NT 10-K
TVGN
Tevogen Bio Holdings Inc.
2 Apr 24
Notice of late annual filing
4:35pm
8-K
g5gk8
2 Apr 24
Entry into a Material Definitive Agreement
9:22am
8-K
izokn5s4iu64
21 Mar 24
Amendments to Articles of Incorporation or Bylaws
5:07pm
8-K
l7fjx7
21 Feb 24
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:30pm
8-K/A
ya6q5c3ecthbjhphuinb
20 Feb 24
Entry into a Material Definitive Agreement
8:57am
CERT
tcj51wxn2bmo10f6q
14 Feb 24
Certification of approval for exchange listing
6:05pm
8-A12B
ipu nkbi2jtdf1fsr
14 Feb 24
Registration of securities on exchange
5:20pm
8-K
vy8 hw8bcgx679xej
14 Feb 24
Entry into a Material Definitive Agreement
5:18pm
25-NSE
aqb2my 998
14 Feb 24
Exchange delisting
4:06pm
425
se2orb
1 Feb 24
Business combination disclosure
8:27am
8-K
fo1inarq
1 Feb 24
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
8:25am
425
tz2 ellkdh
31 Jan 24
Business combination disclosure
8:27am
424B3
0dt7 f53gvyblr4vr4
24 Jan 24
Prospectus supplement
4:37pm
425
uvmiqs qdd13x5hvx23m
24 Jan 24
Business combination disclosure
4:16pm
8-K
8574i 1sgutsl
24 Jan 24
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
4:15pm
424B3
3b2 tj3zpnn06
24 Jan 24
Prospectus supplement
9:20am